Brad Younggren
Brad Younggren is a strategic advisor to several healthcare and technology organizations, including AI 2030, Alli Connect, AngelMD, CalmWave, and Counsel Health. He co-founded Circulate Health, which was acquired, and has served as Chief Medical Officer and President at multiple companies. His expertise includes healthcare innovation and emergency medicine.
Viome Life Sciences acquires Circulate Health for $15M–$50M to combine at-home diagnostics with therapeutic plasma exchange
Viome Life Sciences has acquired Seattle-based Circulate Health in a deal valued between $15 million and $50 million, combining Viome’s at-home diagnostics and personalized supplements with Circulate’s therapeutic plasma exchange service. The merged company, retaining most Circulate staff, aims to expand plasma-exchange clinics, add diagnostics and study biomarkers related to chronic disease and aging.
Seattle Startup Circulate Health Raises $12M to Expand $8,000-$10,000 Plasma Exchange Longevity Treatment
Seattle's Circulate Health raised $12 million in seed funding to expand its costly therapeutic plasma exchange service aimed at promoting longevity by cleaning blood plasma. The company partners with clinics across eight states and has delivered over 1,000 treatments since May 2024, although the procedure is not proven to slow aging or covered by insurance.
98point6 CMO and EvergreenHealth ER Physician Dr. Brad Younggren Says COVID-19 Will Lastingly Change Healthcare After Early Kirkland Outbreak and Vaccine Receipt
Dr. Brad Younggren, chief medical officer at Seattle telehealth startup 98point6 and emergency physician at EvergreenHealth in Kirkland, reflects on treating early U.S. COVID-19 patients, rapid growth in virtual care demand, and receiving the vaccine with cautious optimism. He warns the pandemic isn’t over and says COVID-19 will have lasting effects on healthcare science, technology, and worker well-being.
98point6 raises $43M to triple physician capacity after 200% patient surge, serving 3M nationwide
Seattle telehealth startup 98point6 raised $43 million to expand capacity for its AI-powered virtual primary care amid a 200% surge in patient volume and COVID-19 demand. The funding will triple the company’s physician count this month as it serves over 3 million patients across all 50 states and added coronavirus screening in January.
Organizations
See all 29-
Vindara Health Advisor 2026–present · current
-
Viome Life Sciences President 2026–present · current
-
AI 2030 Strategic Advisor 2024–present · current
Education
-
Royal Society of the Apothecaries, London, U.K. Diplomate in the Medical Care of Catastrophes (DMCC), Disaster Medicine · 1999–2003
-
Uniformed Services University MD, Medicine · 1995–1999
-
UCLA B.A., Political Science · 1991–1995